Study of FMR1 gene association with ovarian dysfunction in a sample from the Basque Country

Gene

Volumn 521, Issue 1, 2013, Pages 145-149

  Barasoain, Maitane ^a   Barrenetxea, Gorka ^b   Huerta, Iratxe ^a   Télez, Mercedes ^a   Carrillo, Amaia ^b   Pérez, Cristina ^b   Criado, Begoña ^c   Arrieta, Isabel ^a  

^a UNIVERSITY OF THE BASQUE COUNTRY UPV EHU   (Spain)

^b Center for Reproductive Medicine and Infertility Quirón Bilbao   (Spain)

^c INSTITUTO DE INVESTIGAÇÃO E FORMAÇÃO AVANÇADA EM CIÊNCIAS E TECNOLOGIAS DA SAÚDE   (Portugal)

Author keywords

Basque Country; FMR1 gene; Intermediate alleles; Ovarian dysfunction; Premutation

Indexed keywords

FOLLITROPIN; FRAGILE X MENTAL RETARDATION PROTEIN; GONADOTROPIN;

ADULT; ALLELE; AMENORRHEA; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; DNA DETERMINATION; FEMALE; FEMALE FERTILITY; GENETIC MARKER; HORMONE DETERMINATION; HUMAN; OVARIAN RESERVE; OVARY FUNCTION; OVARY INSUFFICIENCY; PRIORITY JOURNAL; RETROSPECTIVE STUDY;

ADULT; AMENORRHEA; CASE-CONTROL STUDIES; FEMALE; FOLLICLE STIMULATING HORMONE; FRAGILE X MENTAL RETARDATION PROTEIN; HUMANS; OVARY; PRIMARY OVARIAN INSUFFICIENCY; RETROSPECTIVE STUDIES; SPAIN; TRINUCLEOTIDE REPEAT EXPANSION;

EID: 84876727499     PISSN: 03781119     EISSN: 18790038     Source Type: Journal    
DOI: 10.1016/j.gene.2013.03.032     Document Type: Article

References (78)

1. Ahmed Ebbiary N.A., Lenton E.A., Salt C., Ward A.M., Cooke I.D. The significance of elevated basal follicle stimulating hormone in regularly menstruating infertile women. Hum. Reprod. 1994, 9(2):245-252.
2. Allen E.G., et al. Examination of reproductive aging milestones among women who carry the FMR1 premutation. Hum. Reprod. 2007, 22(8):2142-2152.
3. Allingham-Hawkins D.J., et al. Fragile X premutation is a significant risk factor for premature ovarian failure: the International Collaborative POF in Fragile X study-preliminary data. Am. J. Med. Genet. 1999, 83(4):322-325.
4. Arrieta M.I., Martínez B., Criado B., Simón A., Salazar L., Lostao C.M. Dermatoglyphic analysis of autistic Basque children. Am. J. Med. Genet. 1990, 35(1):1-9.
5. Arrieta I., et al. Cytogenetic study of fragile sites and sister chromatid intercrossing. Cytologia 1993, 58:351-354.
6. Arrieta M.I., et al. a-b ridge count in a Basque population: fluctuating asymmetry and comparison with other populations. Hum. Biol. 1995, 67(1):121-133.
7. Arrieta I., Núñez M., Gil A., Flores P., Usobiaga E., Martínez B. Autosomal folate sensitive fragile sites in an autistic Basque Sample. Ann. Genet. 1996, 39(2):69-94.
8. Arrieta I., Echarri A., Núñez M., Gil A., Criado B., Martínez B. Cytogenetics of autosomal fragile sites: a Basque population study. Am. J. Hum. Biol. 1996, 8:473-481.
9. Arrieta M.I., et al. Study of a trimeric tandem repeat locus SBMA in the Basque population: comparison with other populations. Gene Geogr. 1997, 11(1):61-72.
10. Arrieta I., et al. A survey of fragile X syndrome in a sample from Spanish Basque Country. Ann. Genet. 1999, 42(4):197-201.
11. Arrieta I., et al. Stability of the FMR1 CGG repeat in a Basque sample. Hum. Biol. 1999, 71(1):55-68.
12. Arrieta I., Núñez T., Criado B., Martínez B., Télez M., Lostao C.M. Dermatoglyphic asymmetry in autistic Basques: discriminant analysis. The Science of Finger and Palm Prints 2000, 73-95. Mellen Press, USA. N.M. Durham, K.M. Fox, C.C. Plato (Eds.).
13. Arrieta I., et al. Chromosomal fragility in a behavioral disorder. Behav. Genet. 2002, 32(6):397-412.
14. Arrieta I., et al. The FMR1 CGG repeat and linked microsatellite markers in two Basque valleys. Heredity 2003, 90(3):206-211.
15. Arrieta I., et al. Dermatoglyphic variation in Spanish Basque populations. Hum. Biol. 2003, 75(2):265-291.
16. Arrieta I., Peñagarikano O., Télez M., Ortega B., Criado B., Lostao C.M. Chromosomal fragility and autism. Focus on Autism Research 2004, 398-416. Nova Science Publishers, Inc., New York. O.T. Ryaskin (Ed.).
17. Arrieta M.I., et al. Analysis of the fragile X trinucleotide repeat in Basques: association of premutation and intermediate sizes, anchoring AGGs and linked microsatellites with unstable alleles. Curr. Genomics 2008, 9(3):191-199.
18. Arrieta M.I., et al. Fragile X gene stability in Basque valleys: prevalence of premutation and intermediate/grey zone alleles. Hum. Biol. 2008, 80(6):6-12.
19. Barasoain M., et al. Single nucleotide polymorphism and FMR1 CGG repeat instability in two Basque valleys. Ann. Hum. Genet. 2012, 76(2):110-120.
20. Beckers N.G., Macklon N.S., Eijkemans M.J., Fauser B.C. Women with regular menstrual cycles and poor response to ovarian hyperstimulation for in vitro fertilization exhibit follicular phase characteristics suggestive of ovarian ageing. Fertil. Steril. 2002, 78(2):291-297.
21. Bennett C.E., Conway G.S., Macpherson J.N., Jacobs P.A., Murray A. Intermediate sized CGG repeat are not a common cause of idiopathic premature ovarian failure. Hum. Reprod. 2010, 25(5):1335-1338.
22. Bodega B., et al. Influence of intermediate and uninterrupted FMR1 CGG expansions in premature ovarian failure manifestation. Hum. Reprod. 2006, 21(4):952-957.
23. Braat D.D.M., Smith A.P.T., Thomas C.M.G. Menstrual disorders and endocrine profiles in fragile X carriers prior to 40years of age. Am. J. Med. Genet. 1999, 83:327-328.
24. Bretherick K.L., Fluker M.R., Robinson W.P. FMR1 repeat sizes in the gray zone and high end of the normal range are associated with premature ovarian failure. Hum. Genet. 2005, 117(4):376-382.
25. Buckler H.M., Evans C.A., Mamtora H., Burger H.G., Anderson D.C. Gonadotropin, steroid, and inhibin levels in women with incipient ovarian failure during anovulatory and ovulatory rebound cycles. J. Clin. Endocrinol. Metab. 1991, 72(1):116-124.
26. Cameron I.T., O'Shea F.C., Rolland J.M., Hughes E.G., de Kretser D.M., Healy D.L. Occult ovarian failure: a syndrome of infertility, regular menses and elevated follicle stimulating hormone concentrations. J. Clin. Endocrinol. Metab. 1988, 67(6):1190-1194.
27. Cavalli-Sforza L.L. Genes, peoples and languages. Sci. Am. 1991, 265(5):104-110.
28. Cavalli-Sforza L.L., Piazza A. Human genomic diversity in Europe: a summary of recent research and prospects for the future. Eur. J. Hum. Genet. 1993, 1(1):3-18.
29. Coulam C.B., Adamson S.C., Annegers J.F. Incidence of premature ovarian failure. Obstet. Gynecol. 1986, 67(4):604-606.
30. Creus M., et al. Day 3 serum inhibin B and FSH and age as predictors of assisted reproduction treatment outcome. Hum. Reprod. 2000, 15(11):2341-2346.
31. Cronister A., Schreiner R. Heterozygous fragile X female: historical, physical, cognitive, and cytogenetic features. Am. J. Med. Genet. 1991, 38(2-3):269-274.
32. De Caro J.J., Dominguez C., Sherman S. Reproductive health of adolescent girls who carry the FMR1 premutation. Ann. N. Y. Acad. Sci. 2008, 1135:99-111.
33. De Moraes-Ruehsen M., Jones G.S. Premature ovarian failure. Fertil. Steril. 1967, 18(4):440-461.
34. Ennis S., Ward D., Murray A. Nonlinear association between CGG repeat number and age of menopause in FMR1 premutation carriers. Eur. J. Hum. Genet. 2006, 14(2):253-255.
35. Farhi J., Homburg R., Ferber A., Orvieto R., Ben Rafael Z. Non-response to ovarian stimulation in normogonadotrophic, normogonadal women: a clinical sign of impending onset of ovarian failure pre-empting the rise of basal follicle stimulating hormone levels. Hum. Reprod. 1997, 12(2):241-243.
36. Fernandez-Carvajal I., Lopez Posadas B., Pan R., Raske C., Hagerman P.J., Tassone F. Expansion of an FMR1 grey-zone allele to a full mutation in two generations. J. Mol. Diagn. 2009, 11(4):306-310.
37. Fu Y.H., et al. Variation of the CGG repeat at the fragile X site results in genetic instability: resolution of the Sherman paradox. Cell 1991, 67(6):1047-1058.
38. Gleicher N., Weghofer A., Barad D.H. A pilot study of premature ovarian senescence: I. Correlation of triple CGG repeats on the FMR1 gene to ovarian reserve parameters FSH and anti-Müllerian hormone. Fertil. Steril. 2009, 91(5):1700-1706.
39. Gleicher N., Weghofer A., Oktay K., Barad D. Relevance of triple CGG repeats in the FMR1 gene to ovarian reserve. Reprod. Biomed. Online 2009, 19(3):385-390.
40. Gleicher N., Weghofer A., Oktay K., Barad D.H. Correlation of triple repeats on the FMR1 (fragile x) gene to ovarian reserve: a new infertility test?. Acta Obstet. Gynecol. Scand. 2009, 88(9):1024-1030.
41. Goswami D., Conway G.S. Premature ovarian failure. Horm. Res. 2007, 68(4):196-202.
42. Hagerman R.J., et al. Intention tremor, parkinsonism, and generalized brain atrophy in male carriers of fragile X. Neurology 2001, 57(1):127-130.
43. Healy D.L. Occult ovarian failure. Curr. Ther. Endocrinol. Metab. 1994, 5:198-199.
44. Hundscheid R.D., et al. Imprinting effect in premature ovarian failure confined to paternally inherited fragile X premutations. Am. J. Hum. Genet. 2000, 66(2):413-418.
45. Hundscheid R.D., Braat D.D., Kiemeney L.A., Smits A.O., Thomas C.M. Increased serum FSH in female fragile X premutation carriers with either regular menstrual cycles or on oral contraceptives. Hum. Reprod. 2001, 16(3):457-462.
46. Hundscheid R.D., Smits A.O., Thomas C.M., Kiemeney L.A., Braat D.D. Female carriers of fragile X permutations have no increased risk for additional diseases other than premature ovarian failure. Am. J. Med. Genet. 2003, 117A(1):6-9.
47. Hunter J.E., Epstein M.P., Tinker S.W., Charen K.H., Sherman S.L. Fragile X-associated primary ovarian insufficiency: evidence for additional genetic contributions to severity. Genet. Epidemiol. 2008, 32(6):553-559.
48. Jin M., Yiqui Yu, Huang H. An update on primary ovarían insufficiency. Sci. China Life Sci. 2012, 55(8):677-686.
49. Kalantaridou S.N., Vanderhoof V.H., Calis K.A., Corrigan E.C., Troendle J.F., Nelson L.M. Sexual function in young women with spontaneous 46, XX primary ovarian insufficiency. Fertil. Steril. 2007, 90(5):1805-1811.
50. Karimov C.B., et al. Increased frequency of occult fragile X-associated primary ovarian insufficiency in infertile women with evidence of impaired ovarian function. Hum. Reprod. 2011, 26(8):2077-2083.
51. Livshyts A.B., Kravchenko S.A., Berestovoy A., Zinchenko V.M., Livshits L.A. Allelic polymorphism of the CGG repeat region in the FMR1 gene in patients with impaired natural and stimulated ovulation. Cytol. Genet. 2010, 44:365-369.
52. Mallolas J., et al. Implications of the FMR1 gene in menopause: study of 147 Spanish women. Menopause 2001, 8(2):106-110.
53. Murray A., Webb J., MacSwiney F., Shipley E.L., Morton N.E., Conway G.S. Serum concentrations of follicle stimulating hormone may predict premature ovarian failure in FRAXA premutation women. Hum. Reprod. 1999, 14(5):1217-1218.
54. Murray A., Ennis S., MacSwiney F., Webb J., Morton N.E. Reproductive and menstrual history of females with fragile X expansions. Eur. J. Hum. Genet. 2000, 8(4):247-252.
55. Nelson L.M. An update: spontaneous premature ovarian failure is not an early menopause. Fertil. Steril. 2005, 83(5):1327-1332.
56. Oberlé I., et al. Instability of a 550-base pair DNA segment and abnormal methylation in fragile X syndrome. Science 1991, 252(5009):1097-1102.
57. Partington M.W., Moore D.Y., Turner G.M. Confirmation of early menopause in fragile X carriers. Am. J. Med. Genet. 1996, 64(2):370-372.
58. Peñagarikano O., et al. A new insight into fragile X syndrome among Basque population. Am. J. Med. Genet. A 2004, 128A(3):250-255.
59. Rohr J., et al. Anti-Mullerian hormone indicates early ovarian decline in fragile X mental retardation (FMR1) premutation carriers: a preliminary study. Hum. Reprod. 2008, 23:1220-1225.
60. Sambrook J., Fritsch E.F., Maniatis T. Molecular Cloning: a Laboratory Manual 1989, Cold Spring Harbor Laboratory, New York. 2nd ed.
61. Schwartz C.E., et al. Obstetrical and gynecological complications in fragile X carriers: a multi-center study. Am. J. Med. Genet. 1994, 51(4):400-402.
62. Sherman S.L., Taylor K., Allen E. FMR1 premutation: a leading cause of inherited ovarian dysfunction. Fragile Sites: New Discoveries and Changing Perspectives 2007, 299-320. Nova Science Publishers, Inc., New York. I. Arrieta, O. Penagarikano, M. Télez (Eds.).
63. Streuli I., Fraisse T., Ibecheole V., Moix I., Morris M.A., de Ziegler D. Intermediate and premutation FMR1 alleles in women with occult primary ovarian insufficiency. Fertil. Steril. 2009, 92(2):464-470.
64. Sullivan A.K., Crawford D.C., Scott E.H., Leslie M., Sherman S.L. Paternally transmitted FMR1 alleles are less stable than maternally transmitted alleles in the common and intermediate size range. Am. J. Hum. Genet. 2002, 70(6):1532-1544.
65. Sullivan A.K., et al. Association of FMR1 repeat size with ovarian dysfunction. Hum. Reprod. 2005, 20(2):402-412.
66. Télez M., et al. Assessment of the genotoxicity of atenolol in human peripheral blood lymphocytes: correlation between chromosomal fragility and content of micronuclei. Mutat. Res. 2010, 695(1-2):46-54.
67. Terracciano A., et al. Expansion to full mutation of a FMR1 intermediate allele over two generations. Eur. J. Hum. Genet. 2004, 12(4):333-336.
68. Van Esch H., Buekenhout L., Race V., Matthijs G. Very early premature ovarian failure in two sisters compound heterozygous for the FMR1 premutation. Eur. J. Med. Genet. 2009, 52(1):37-40.
69. Verkerk A.J., et al. Identification of a gene (FMR-1) containing a CGG repeat coincident with a breakpoint cluster region exhibiting length variation in fragile X syndrome. Cell 1991, 65(5):905-914.
70. Vianna-Morgante A.M., Costa S.S., Pares A.S., Verreschi I.T. FRAXA premutation associated with premature ovarian failure. Am. J. Med. Genet. 1996, 64(2):373-375.
71. Vianna-Morgante A.M., Costa S.S., Pavanello R.C., Otto P.A., Mingroni-Netto R.C. Premature ovarian failure (POF) in Brazilian fragile X carriers. Genet. Mol. Biol. 1999, 22:471-474.
72. Wang T., Bray S.M., Warren S.T. New perspectives on the biology of Fragile X Syndrome. Curr. Opin. Genet. Dev. 2012, 22(3):256-263.
73. Welt C.K. Primary ovarian insufficiency: a more accurate term for premature ovarian failure. Clin. Endocrinol. (Oxf) 2008, 68(4):499-509.
74. Welt C.K., Smith P.C., Taylor A.E. Evidence of early ovarian aging in fragile x premutation carriers. J. Clin. Endocrinol. Metab. 2004, 89(9):4569-4574.
75. Wittenberger M.D., et al. The FMR1 premutation and reproduction. Fertil. Steril. 2007, 87(3):456-465.
76. Yu S., et al. Fragile X genotype characterized by an unstable region of DNA. Science 1991, 252(5009):1179-1181.
77. Zietkiewicz E., et al. Haplotypes in the dystrophin DNA segment point to a mosaic origin of modern human diversity. Am. J. Hum. Genet. 2003, 73(5):994-1015.
78. Zuñiga A., Juan J., Mila M., Guerrero A. Expansion of an intermediate allele of the FMR1 gene in only two generations. Clin. Genet. 2005, 68(5):471-473.